Pasture Holdings warns of 1H2026 net loss on weaker pharma margins, supply-chain disruptions
Summary:
-
Pasture Holdings expects to report a net loss for the half year ended 31 December 2025 (1H2026), reversing from a profitable 1H2025.
-
The shortfall stems mainly from lower revenue and thinner gross margins in its pharmaceutical wholesale and distribution segment versus the same period a year earlier.
-
Management cites supply-chain disruptions across key markets and higher compliance costs for cross-border pharmaceutical shipments as key drags on profitability.
-
The Group warns that supply-chain issues, heightened compliance requirements and geopolitical uncertainty are likely to persist into the second half, with potential material impact on FY ending 30 June 2026.
-
Pasture plans to release its unaudited 1H2026 results on or before 13 February 2026 and advises investors to exercise caution when dealing in its shares.